Interventional Differences Among Huntington's Disease Patients by Disease Progression in Commercial and Medicaid Populations-Reference-Cited by-同舟云学术

Interventional Differences Among Huntington's Disease Patients by Disease Progression in Commercial and Medicaid Populations

Published:2014 Issue:4 Volume:3 Page:355-363
ISSN:1879-6397
Container-title:Journal of Huntington's Disease
language:
Short-container-title:

Author:

Anderson Karen E.¹,Divino Victoria²,DeKoven Mitch²,Langbehn Douglas³,Warner John H.⁴,Giuliano Joseph⁴,Lee Won Chan²

Affiliation:

1. MedStar Georgetown University Hospital & Georgetown University Medical Center – Huntington Disease Care, Education & Research Center, Wisconsin Avenue NW, Washington, DC, USA

2. IMS Health, Willow Oaks Corporate Drive, Fairfax, VA, USA

3. University of Iowa – Department of Psychiatry, Hawkins Drive, Iowa City, IA, USA

4. CHDI Management/CHDI Foundation, Village Boulevard, Princeton, NJ, USA

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Clinical Neurology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington’s disease: a claims‑based retrospective cohort study;Journal of Medical Economics;2023-07-03

2. Healthcare utilization and direct medical costs of Huntington’s disease among Medicaid beneficiaries in the United States;Journal of Medical Economics;2023-06-23

3. Health care resource utilization and costs among individuals with vs without Huntington disease in a US population;Journal of Managed Care & Specialty Pharmacy;2022-11

4. Healthcare resource utilization and costs in individuals with Huntington’s disease by disease stage in a US population;Journal of Medical Economics;2022-06-03

5. Healthcare utilization and cost burden of Huntington’s disease among Medicare beneficiaries in the United States;Journal of Medical Economics;2021-01-01